2-227815529-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_004591.3(CCL20):c.152G>A(p.Arg51Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,458,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004591.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL20 | NM_004591.3 | c.152G>A | p.Arg51Gln | missense_variant | 2/4 | ENST00000358813.5 | NP_004582.1 | |
CCL20 | NM_001130046.2 | c.149G>A | p.Arg50Gln | missense_variant | 2/4 | NP_001123518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL20 | ENST00000358813.5 | c.152G>A | p.Arg51Gln | missense_variant | 2/4 | 1 | NM_004591.3 | ENSP00000351671 | P4 | |
CCL20 | ENST00000409189.7 | c.149G>A | p.Arg50Gln | missense_variant | 2/4 | 1 | ENSP00000386273 | A1 | ||
CCL20 | ENST00000473642.1 | n.161G>A | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
CCL20 | ENST00000489160.1 | n.218G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 249948Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135180
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1458298Hom.: 0 Cov.: 29 AF XY: 0.0000179 AC XY: 13AN XY: 725706
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at